Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma

被引:31
|
作者
Hong, A
Davies, S
Lee, CS
机构
[1] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia
[2] Royal Prince Alfred Hosp, Dept Radiat Oncol, Sydney, NSW, Australia
[3] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW, Australia
关键词
Kaposi's sarcoma; neoplasm; human herpes virus 8; HHV8; immunohistochemistry;
D O I
10.1080/00313020310001602657
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: The molecular genetics of the human herpes virus 8 (HHV8) has now been characterised and the virus appears to be important in the pathogenesis of Kaposi's sarcoma (KS). This study attempts to determine the rate of HHV8 infection in KS in an Australian cohort. Methods: Routine streptavidin-biotin-peroxidase immunostaining with diaminobenzidine was performed on paraffin-embedded archival tissues of 37 KS cases using a murine monoclonal antibody directed against the C-terminus of the latent nuclear antigen-1 molecule of HHV8 (clone 13B10; Novocastra) at 1:50 dilution. Results: Positive HHV8 nuclear staining was detected in the nuclei of the spindle cells and endothelial cells of the vascular channels in about 78% (29/37) of all cases. HHV8 staining was absent in the non-neoplastic vessels in the adjacent tissue ( P =0.0001, chi 2 =44.46; chi 2 -test with continuity correction) and the negative control cases of Merkel cell carcinoma ( P =0.02, chi 2 =5.07; chi 2 -test with continuity correction). HHV8 staining was detected in 80% (8/10 cases) of the patch stage, 88% (7/8 cases) of the plaque stage and 74% (14/19 cases) of the late stage. No significant difference was found between HHV8 positivity and HIV status, age, gender, tumour recurrence, multiplicity or site of the lesions. Conclusions: The latent nuclear antigen-1 of HHV8 can be detected by immunohistochemistry in the majority of human KS lesions, raising the possibility of its future potential use as an adjunct for the diagnosis of KS in problematic cases.
引用
收藏
页码:448 / 450
页数:3
相关论文
共 50 条
  • [21] Utility of the immunohistochemical detection of HHV-8 in the diagnosis of Kaposi's sarcoma
    Patel, RM
    Goldblum, JR
    Hsi, ED
    MODERN PATHOLOGY, 2003, 16 (01) : 19A - 19A
  • [22] HHV8 status in Kaposi's sarcoma associated with multiple myeloma
    Le Gars, L
    Agbalika, F
    Picard, O
    Kaplan, G
    Berenbaum, F
    REVUE DU RHUMATISME, 1998, 65 (12): : 788 - 790
  • [23] Utility of the immunohistochemical detection of HHV-8 in the diagnosis of Kaposi's sarcoma
    Patel, RM
    Goldblum, JR
    Hsi, ED
    LABORATORY INVESTIGATION, 2003, 83 (01) : 19A - 19A
  • [24] Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers
    Cheuk, W
    Wong, KOY
    Wong, CSC
    Dinkel, JE
    Ben-Dor, D
    Chan, JKC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (03) : 335 - 342
  • [25] Cyclin D1 expression and HHV8 in Kaposi sarcoma
    Kennedy, MM
    Biddolph, S
    Lucas, SB
    Howells, DD
    Picton, S
    McGee, JO
    Silva, I
    Uhlmann, V
    Luttich, K
    O'Leary, JJ
    JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (08) : 569 - 573
  • [27] Kaposi's sarcoma and HHV8:: a new model of virus-induced tumorigenesis.
    Pellet, C
    Lebbé, C
    PATHOLOGIE BIOLOGIE, 2000, 48 (06): : 529 - 532
  • [28] Human herpes virus 8 (HHV8) and pyothorax associated lymphoma (PAL)
    O'Leary, JJ
    Silva, I
    Uhlmann, V
    Prassad, M
    Luttich, K
    Lohman, K
    Howells, D
    Picton, S
    Pileri, S
    JOURNAL OF PATHOLOGY, 1998, 186 : 8A - 8A
  • [29] Human herpes virus 8 (Kaposi's sarcoma herpesvirus)
    Porter, SR
    Di Alberti, L
    Kumar, N
    ORAL ONCOLOGY, 1998, 34 (01) : 5 - 14
  • [30] Human herpes virus 8 (HHV8): Detection in peripheral blood mononuclear cells (PBMC) from Venezuelan patients with human immunodeficienccy virus-1 (HIV-1) infection with/without Kaposi's sarcoma (KS)
    Hernandez-Morales, D. E.
    Riera, J.
    Pinto, J.
    Marin, M. E.
    Lopez, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)